首页> 外国专利> Piperidin-4-il-urea derivatives; pharmacodynamic synthesis; and as Grelina receptor antagonists in the treatment of obesity, eating disorders, diabetes, cancer-induced thrombosis, congestive heart failure, etc.

Piperidin-4-il-urea derivatives; pharmacodynamic synthesis; and as Grelina receptor antagonists in the treatment of obesity, eating disorders, diabetes, cancer-induced thrombosis, congestive heart failure, etc.

机译:Piperidin-4-il-urea衍生物;药效合成;并作为Grelina受体拮抗剂治疗肥胖,进食障碍,糖尿病,癌症引起的血栓形成,充血性心力衰竭等。

摘要

Disclosed are compounds, compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically mediated by the ghrelin receptor. The compounds have the general formula (I):
机译:公开了用于预防和/或治疗由生长素释放肽受体在病理生理学上介导的疾病的化合物,组合物和方法。这些化合物具有通式(I):

著录项

  • 公开/公告号CL2013002412A1

    专利类型

  • 公开/公告日2014-02-07

    原文格式PDF

  • 申请/专利权人 HELSINN HEALTHCARE SA;

    申请/专利号CL20130002412

  • 申请日2013-08-21

  • 分类号C07D211/58;A61K31/4468;A61P1/00;A61P1/04;A61P1/16;A61P21/00;A61P25/00;A61P25/30;A61P25/32;A61P25/36;A61P3/00;A61P3/04;A61P3/06;A61P3/08;A61P3/10;A61P5/48;A61P7/00;A61P9/00;A61P9/04;A61P9/10;A61P9/12;

  • 国家 CL

  • 入库时间 2022-08-21 15:58:30

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号